289 related articles for article (PubMed ID: 3149640)
1. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
2. Human articular cartilage contains an inhibitor of plasminogen activator.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
[TBL] [Abstract][Full Text] [Related]
4. Secretion of plasminogen activator inhibitor by cultured human epidermal cells.
Hashimoto K; Nishioka K; Katayama I; Yoshikawa K
Br J Dermatol; 1986 Aug; 115(2):133-8. PubMed ID: 3091060
[TBL] [Abstract][Full Text] [Related]
5. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
van Mourik JA; Lawrence DA; Loskutoff DJ
J Biol Chem; 1984 Dec; 259(23):14914-21. PubMed ID: 6438106
[TBL] [Abstract][Full Text] [Related]
6. Platelet release protein which inhibits plasminogen activators.
Booth NA; Anderson JA; Bennett B
J Clin Pathol; 1985 Jul; 38(7):825-30. PubMed ID: 3926830
[TBL] [Abstract][Full Text] [Related]
7. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
Philips M; Juul AG; Thorsen S
Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
[TBL] [Abstract][Full Text] [Related]
8. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
Wagner OF; Vetterlein M; Binder BR
J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
[TBL] [Abstract][Full Text] [Related]
9. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
Wun TC; Reich E
J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
Booyse FM; Osikowicz G; Feder S; Scheinbuks J
J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.
Crutchley DJ; Conanan LB
J Biol Chem; 1986 Jan; 261(1):154-9. PubMed ID: 3079753
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
[TBL] [Abstract][Full Text] [Related]
13. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
14. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
[TBL] [Abstract][Full Text] [Related]
16. Purification of epidermal plasminogen activator inhibitor.
Hibino T; Izaki S; Izaki M
FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
[TBL] [Abstract][Full Text] [Related]
17. Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
Golder JP; Stephens RW
Eur J Biochem; 1983 Nov; 136(3):517-22. PubMed ID: 6416839
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
19. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
Thorsen S; Philips M
Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
[TBL] [Abstract][Full Text] [Related]
20. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
Booth NA; Anderson JA; Bennett B
Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]